HIV/AIDS community activism not only pushed the FDA, NIH, Congress and drugmakers to devote resources to the deadly disease, it also opened a new front in drug development: the science of patient input. FasterCures is among the groups developing tools that industry and nonprofit organizations can use to learn about patients' experiences and priorities, and incorporate those data into drug development. "We're learning how we can get insights from patients earlier in the development process," FasterCures Executive Director Margaret Anderson said.
FasterCures developing tools for the science of patient input
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.